Delivery Order SPE2DR25D3103-SPE2DR26F9X33
- Not listed
- The Defense Logistics Agency awarded a $3,594.48 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s, larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,703.31 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a $4,176.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.15 mg epinephrine auto-injectors (two-pack units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,178.39 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-inject auto-injectors (2-pack). This competitively awarded, firm fixed-price contract was executed on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs under a firm fixed price contract valued at $2,491.96. This is a non-set-aside competitive award, with an ultimate completion date of August 19, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $5,625.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of epinephrine 0.3 mg auto-injector kits (2-packs). This competitive award, which carries an ultimate completion date of January 13, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The delivery will be fulfilled from the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $2,264.83 and an ultimate completion date of January 15, 2026. This non-set-aside contract was competitively awarded and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026),...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,436.61 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This contract represents a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and was competitively awarded without any set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $4,329.63 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitive, non-set-aside contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and operates under firm fixed price terms. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $1,797.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The ultimate completion date is November 18, 2025, with the award...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9X33Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,567.26 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (two-pack units) on January 14, 2026, with a completion date of January 15, 2026. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a critical distributor for military and federal healthcare systems. This delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031. That prime contract vehicle enables comprehensive pharmaceutical and medical supply deliveries globally to support military healthcare programs, including specialty medications, generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen's federal contracting portfolio demonstrates consistent competitively awarded procurement relationships with DLA and other federal agencies, reflecting the company's established capability to efficiently fulfill essential pharmaceutical requirements for military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 1/13/26 |